IBD patients have been found to have a higher risk of lymphoma.

Silent Reflux: Clinical Conundrum Solved via Proper Testing

A chronic cough without heartburn are the tell-tale signs of the condition; surgery is typically not the answer.

Zenocutuzumab OK’d for NRG1 Fusion+ Cholangiocarcinoma

The bispecific antibody has previously granted accelerated approval for advanced, unresectable, or metastatic non-small cell lung cancer and pancreatic adenocarcinoma harboring the gene fusions.

Sigmoidoscopy Cuts Colorectal Cancer Risk in Men

Researchers randomly assign more than 100,000 adults without CRC to receive once-only sigmoidoscopy screening or no screening between 1999 and 2001. Here’s what they find.

False Positive mt-sDNA Tests Could Flag Other Cancers

False-positive multi-target stool tests are linked to higher rates of noncolorectal aerodigestive cancers, suggesting further workup may be indicated in these patients.

HER2 Testing in Practice: Case-Based Insights to Improve Interpretation, Reporting, and Multidisciplinary Team Collaboration

HER2 Testing in Practice: Case-Based Insights to Improve Interpretation, Reporting, and Multidisciplinary Team Collaboration

Meeting the Challenge of Accurate and Timely Diagnosis of GEP-NETs

Meeting the Challenge of Accurate and Timely Diagnosis of GEP-NETs

Unlocking MMR and MSI: Paving the Path to Personalized Treatment in Early-Stage CRC

Unlocking MMR and MSI: Paving the Path to Personalized Treatment in Early-Stage CRC

Navigating Personalized Management of Advanced Upper GI Adenocarcinomas

Navigating Personalized Management of Advanced Upper GI Adenocarcinomas

Precision Pathways: Matching Test Results to Therapy in Advanced G/GEJ Adenocarcinoma

Precision Pathways: Matching Test Results to Therapy in Advanced G/GEJ Adenocarcinoma

Clinical Pearls to Advance Multidisciplinary Team-Based Care for Patients With GEP-NETs

Clinical Pearls to Advance Multidisciplinary Team-Based Care for Patients With GEP-NETs

Navigating the Future of Upper GI Cancer Treatment: Mechanisms, Personalization, and Expert Insights

Navigating the Future of Upper GI Cancer Treatment: Mechanisms, Personalization, and Expert Insights

Checkpoint, Claudin, and Beyond: Optimizing Biomarker-Driven Decisions in Advanced/Metastatic G/GEJ Cancer Care

Checkpoint, Claudin, and Beyond: Optimizing Biomarker-Driven Decisions in Advanced/Metastatic G/GEJ Cancer Care

EASL: European Association for the Study of the Liver

CCC: Crohn's & Colitis Congress

AASLD: American Association for the Study of Liver Diseases

ACG: American College of Gastroenterology